ProtoQsar

ProtoQSAR is a Spanish SME with 10-years experience, specialized in the design and development of drugs and other chemical substances. This includes design, optimization, valorization, and development of small molecules, peptides, nanomaterials… as well as drug reprofiling and virtual screening. We are experts in the latest Artificial Intelligence-powered chemoinformatics and structural bioinformatics tools, including QSAR models, molecular docking, pharmacophore modelling, homology modelling, molecular dynamics, and molecular mechanics analyses.

We work in drug design and development, chemistry and regulatory toxicology and discovery and development of other compounds in the biotech, pharma, veterinary, cosmetics, nutraceuticals, materials, and agrifood sectors.

We have experience in 10+ international research projects, including the HORIZON projects “ONTOX” (and ASPIS cluster), HYPIEND, BIO-SUSHY, and 25+ other projects, and our team has 80+ publications in our topics of interest.

Regarding drug discovery and development, our pipeline of services cover all the value chain …

Regarding our QSAR models allow for the prediction and assessment of physicochemical, biological, therapeutical, pharmacological (e.g. ADME), and/or (eco)toxicological properties of substances with an array of advantages:
· fast results,
· saving of material and financial resources,
· regulatory validity with automatic QMRF and QPRF,
· reduced animal testing (3Rs),
Many of them, including the largest available QSAR platform for REACH, can be directly accessed (including a free trial) at https://protopred.protoqsar.com/